Subcellular fractionation and localization studies reveal a direct interaction of the fragile X mental retardation protein (FMRP) with nucleolin

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Taha, Mohamed S ^a   Nouri, Kazem ^a   Milroy, Lech G ^b   Moll, Jens M ^a   Herrmann, Christian ^c   Brunsveld, Luc ^b   Piekorz, Roland P ^a   Ahmadian, Mohammad R ^a  

^a Department of Orthopedic Surgery   (Germany)

^b EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EVIDENCE BASED MEDICINE; HUMAN; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; LAPAROSCOPIC SURGERY; LENGTH OF STAY; META ANALYSIS; OBSERVATIONAL STUDY; OPERATION DURATION; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PARTIAL NEPHRECTOMY; PATIENT SAFETY; PATIENT SELECTION; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROPERITONEAL LAPAROSCOPIC PARTIAL NEPHRECTOMY; RETROSPECTIVE STUDY; SURGICAL APPROACH; SYSTEMATIC REVIEW; TRANSPERITONEAL LAPAROSCOPIC PARTIAL NEPHRECTOMY; CELL FRACTIONATION; GENE EXPRESSION REGULATION; HELA CELL LINE; METABOLISM; NUCLEAR LOCALIZATION SIGNAL; PROTEIN TRANSPORT;

FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA; NUCLEAR LOCALIZATION SIGNAL; NUCLEOLIN; PHOSPHOPROTEIN; RNA BINDING PROTEIN;

CELL FRACTIONATION; FRAGILE X MENTAL RETARDATION PROTEIN; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; NUCLEAR LOCALIZATION SIGNALS; PHOSPHOPROTEINS; PROTEIN TRANSPORT; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 84899073938     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091465     Document Type: Article

References (76)

1. Krueger DD, Bear MF (2011) Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu Rev Med 62: 411-429.
2. Wang T, Bray SM, Warren ST (2012) New perspectives on the biology of fragile X syndrome. Curr Opin Genet Dev 22: 256-263.
3. Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, et al. (2011) FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146: 247-261.
4. Iacoangeli A, Tiedge H (2013) Translational control at the synapse: role of RNA regulators. Trends Biochem Sci 38: 47-55.
5. Bardoni B, Davidovic L, Bensaid M, Khandjian EW (2006) The fragile X syndrome: exploring its molecular basis and seeking a treatment. Expert Rev Mol Med 8: 1-16.
6. Kim M, Ceman S (2012) Fragile X mental retardation protein: past, present and future. Curr Protein Pept Sci 13: 358-371.
7. Hoogeveen AT, Willemsen R, Oostra BA (2002) Fragile X syndrome, the Fragile X related proteins, and animal models. Microsc Res Tech 57: 148-155. (Pubitemid 34457293)
8. Davidovic L, Durand N, Khalfallah O, Tabet R, Barbry P, et al. (2013) A novel role for the RNA-binding protein FXR1P in myoblasts cell-cycle progression by modulating p21/Cdkn1a/Cip1/Waf1 mRNA stability. PLoS Genet 9:e1003367.
9. El Fatimy R, Tremblay S, Dury AY, Solomon S, De Koninck P, et al. (2012) Fragile X mental retardation protein interacts with the RNA-binding protein Caprin1 in neuronal RiboNucleoProtein complexes [corrected]. PLoS One 7: e39338.
10. Santoro MR, Bray SM, Warren ST (2012) Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annu Rev Pathol 7: 219-245.
11. Feng Y, Absher D, Eberhart DE, Brown V, Malter HE, et al. (1997) FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol Cell 1: 109-118. (Pubitemid 127376398)
12. Tamanini F, Meijer N, Verheij C, Willems PJ, Galjaard H, et al. (1996) FMRP is associated to the ribosomes via RNA. Hum Mol Genet 5: 809-813. (Pubitemid 26171296)
13. Corbin F, Bouillon M, Fortin A, Morin S, Rousseau F, et al. (1997) The fragile X mental retardation protein is associated with poly(A)+ mRNA in actively translating polyribosomes. Hum Mol Genet 6: 1465-1472. (Pubitemid 27397022)
14. Sidorov MS, Auerbach BD, Bear MF (2013) Fragile X mental retardation protein and synaptic plasticity. Mol Brain 6: 15.
15. Adinolfi S, Ramos A, Martin SR, Dal Piaz F, Pucci P, et al. (2003) The Nterminus of the fragile X mental retardation protein contains a novel domain involved in dimerization and RNA binding. Biochemistry 42: 10437-10444. (Pubitemid 37071443)
16. Ramos A, Hollingworth D, Adinolfi S, Castets M, Kelly G, et al. (2006) The structure of the N-terminal domain of the fragile X mental retardation protein: a platform for protein-protein interaction. Structure 14: 21-31. (Pubitemid 43350070)
17. Kim M, Bellini M, Ceman S (2009) Fragile X mental retardation protein FMRP binds mRNAs in the nucleus. Mol Cell Biol 29: 214-228.
18. Feng Y, Gutekunst CA, Eberhart DE, Yi H, Warren ST, et al. (1997) Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci 17: 1539-1547. (Pubitemid 27089800)
19. Bardoni B, Sittler A, Shen Y, Mandel JL (1997) Analysis of domains affecting intracellular localization of the FMRP protein. Neurobiol Dis 4: 329-336. (Pubitemid 28018661)
20. Tamanini F, Bontekoe C, Bakker CE, van Unen L, Anar B, et al. (1999) Different targets for the fragile X-related proteins revealed by their distinct nuclear localizations. Hum Mol Genet 8: 863-869. (Pubitemid 29189054)
21. Willemsen R, Bontekoe C, Tamanini F, Galjaard H, Hoogeveen A, et al. (1996) Association of FMRP with ribosomal precursor particles in the nucleolus. Biochem Biophys Res Commun 225: 27-33. (Pubitemid 26285392)
22. Schenck A, Bardoni B, Moro A, Bagni C, Mandel JL (2001) A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P. Proc Natl Acad Sci U S A 98: 8844-8849. (Pubitemid 32678115)
23. Schenck A, Bardoni B, Langmann C, Harden N, Mandel JL, et al. (2003) CYFIP/Sra-1 controls neuronal connectivity in Drosophila and links the Rac1 GTPase pathway to the fragile X protein. Neuron 38: 887-898. (Pubitemid 36782381)
24. Bardoni B, Willemsen R, Weiler IJ, Schenck A, Severijnen LA, et al. (2003) NUFIP1 (nuclear FMRP interacting protein 1) is a nucleocytoplasmic shuttling protein associated with active synaptoneurosomes. Exp Cell Res 289: 95-107. (Pubitemid 37006343)
25. Bardoni B, Castets M, Huot ME, Schenck A, Adinolfi S, et al. (2003) 82-FIP, a novel FMRP (fragile X mental retardation protein) interacting protein, shows a cell cycle-dependent intracellular localization. Hum Mol Genet 12: 1689-1698. (Pubitemid 36896661)
26. Ceman S, Brown V, Warren ST (1999) Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex. Mol Cell Biol 19: 7925-7932. (Pubitemid 30413987)
27. Villace P, Marion RM, Ortin J (2004) The composition of Staufen-containing RNA granules from human cells indicates their role in the regulated transport and translation of messenger RNAs. Nucleic Acids Res 32: 2411-2420. (Pubitemid 38854795)
28. Galva C, Artigas P, Gatto C (2012) Nuclear Na+/K+-ATPase plays an activerole in nucleoplasmic Ca2 + homeostasis. J Cell Sci 125: 6137-6147.
29. Adjobo-Hermans MJ, Goedhart J, van Weeren L, Nijmeijer S, Manders EM, et al. (2011) Real-time visualization of heterotrimeric G protein Gq activation in living cells. BMC Biol 9: 32.
30. Seidler NW (2013) Compartmentation of GAPDH. Adv Exp Med Biol 985: 61-101.
31. Tisdale EJ, Kelly C, Artalejo CR (2004) Glyceraldehyde-3-phosphate dehydrogenase interacts with Rab2 and plays an essential role in endoplasmic reticulum to Golgi transport exclusive of its glycolytic activity. J Biol Chem 279: 54046-54052. (Pubitemid 40053138)
32. Mu FT, Callaghan JM, Steele-Mortimer O, Stenmark H, Parton RG, et al. (1995) EEA1, an early endosome-associated protein. EEA1 is a conserved alphahelical peripheral membrane protein flanked by cysteine "fingers" and contains a calmodulin-binding IQ motif. J Biol Chem 270: 13503-13511.
33. Shimi T, Butin-Israeli V, Adam SA, Hamanaka RB, Goldman AE, et al. (2011) The role of nuclear lamin B1 in cell proliferation and senescence. Genes Dev 25: 2579-2593.
34. Colombo E, Alcalay M, Pelicci PG (2011) Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases. Oncogene 30: 2595-2609.
35. Tamanini F, Van Unen L, Bakker C, Sacchi N, Galjaard H, et al. (1999) Oligomerization properties of fragile-X mental-retardation protein (FMRP) and the fragile-X-related proteins FXR1P and FXR2P. Biochem J 343 Pt 3: 517-523. (Pubitemid 29537361)
36. Napoli I, Mercaldo V, Boyl PP, Eleuteri B, Zalfa F, et al. (2008) The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell 134: 1042-1054.
37. Bardoni B, Schenck A, Mandel JL (2001) The Fragile X mental retardation protein. Brain Res Bull 56: 375-382. (Pubitemid 33062364)
38. Garcia-Mata R, Boulter E, Burridge K (2011) The 'invisible hand': regulation of RHO GTPases by RHOGDIs. Nat Rev Mol Cell Biol 12: 493-504.
39. Lanning CC, Daddona JL, Ruiz-Velasco R, Shafer SH, Williams CL (2004) The Rac1 C-terminal polybasic region regulates the nuclear localization and protein degradation of Rac1. J Biol Chem 279: 44197-44210. (Pubitemid 39390727)
40. Sandrock K, Bielek H, Schradi K, Schmidt G, Klugbauer N (2010) The nuclear import of the small GTPase Rac1 is mediated by the direct interaction with karyopherin alpha2. Traffic 11: 198-209.
41. Jackson RS, 2nd, Cho YJ, Stein S, Liang P (2007) CYFIP2, a direct p53 target, is leptomycin-B sensitive. Cell Cycle 6: 95-103. (Pubitemid 46178024)
42. Michaelson D, Abidi W, Guardavaccaro D, Zhou M, Ahearn I, et al. (2008) Rac1 accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division. J Cell Biol 181: 485-496. (Pubitemid 351645038)
43. Tajrishi MM, Tuteja R, Tuteja N (2011) Nucleolin: The most abundant multifunctional phosphoprotein of nucleolus. Commun Integr Biol 4: 267-275.
44. Abdelmohsen K, Gorospe M (2012) RNA-binding protein nucleolin in disease. RNA Biol 9: 799-808.
45. Brendel C, Rehbein M, Kreienkamp HJ, Buck F, Richter D, et al. (2004) Characterization of Staufen 1 ribonucleoprotein complexes. Biochem J 384: 239-246. (Pubitemid 39656235)
46. Ceman S, O'Donnell WT, Reed M, Patton S, Pohl J, et al. (2003) Phosphorylation influences the translation state of FMRP-associated polyribosomes. Hum Mol Genet 12: 3295-3305. (Pubitemid 37541075)
47. Caudle WM, Kitsou E, Li J, Bradner J, Zhang J (2009) A role for a novel protein, nucleolin, in Parkinson's disease. Neurosci Lett 459: 11-15.
48. Dolzhanskaya N, Merz G, Aletta JM, Denman RB (2006) Methylation regulates the intracellular protein-protein and protein-RNA interactions of FMRP. J Cell Sci 119: 1933-1946. (Pubitemid 43811018)
49. Huang L, Mollet S, Souquere S, Le Roy F, Ernoult-Lange M, et al. (2011) Mitochondria associate with P-bodies and modulate microRNA-mediated RNA interference. J Biol Chem 286: 24219-24230.
50. Ross-Inta C, Omanska-Klusek A, Wong S, Barrow C, Garcia-Arocena D, et al. (2010) Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome. Biochem J 429: 545-552.
51. Yao A, Jin S, Li X, Liu Z, Ma X, et al. (2011) Drosophila FMRP regulates microtubule network formation and axonal transport of mitochondria. Hum Mol Genet 20: 51-63.
52. Kaplan ES, Cao Z, Hulsizer S, Tassone F, Berman RF, et al. (2012) Early mitochondrial abnormalities in hippocampal neurons cultured from Fmr1 premutation mouse model. J Neurochem 123: 613-621.
53. McLennan Y, Polussa J, Tassone F, Hagerman R (2011) Fragile x syndrome. Curr Genomics 12: 216-224.
54. Blackwell E, Zhang X, Ceman S (2010) Arginines of the RGG box regulate FMRP association with polyribosomes and mRNA. Hum Mol Genet 19: 1314-1323.
55. Callebaut C, Blanco J, Benkirane N, Krust B, Jacotot E, et al. (1998) Identification of V3 loop-binding proteins as potential receptors implicated in the binding of HIV particles to CD4(+) cells. J Biol Chem 273: 21988-21997. (Pubitemid 28405379)
56. Maurer-Stroh S, Dickens NJ, Hughes-Davies L, Kouzarides T, Eisenhaber F, et al. (2003) The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains. Trends Biochem Sci 28: 69-74. (Pubitemid 36165134)
57. Adams-Cioaba MA, Guo Y, Bian C, Amaya MF, Lam R, et al. (2010) Structural studies of the tandem Tudor domains of fragile X mental retardation related proteins FXR1 and FXR2. PLoS One 5: e13559.
58. Scott MS, Troshin PV, Barton GJ (2011) NoD: a Nucleolar localization sequence detector for eukaryotic and viral proteins. BMC Bioinformatics 12: 317.
59. Tamanini F, Kirkpatrick LL, Schonkeren J, van Unen L, Bontekoe C, et al. (2000) The fragile X-related proteins FXR1P and FXR2P contain a functional nucleolar-targeting signal equivalent to the HIV-1 regulatory proteins. Hum Mol Genet 9: 1487-1493. (Pubitemid 30386703)
60. Dury AY, El Fatimy R, Tremblay S, Rose TM, Côté J, et al. (2013) Nuclear Fragile X Mental Retardation Protein Is localized to Cajal Bodies. PLoS Genetics 9: e1003890.
61. Brackett DM, Qing F, Amieux PS, Sellers DL, Horner PJ, et al. (2013) FMR1 transcript isoforms: association with polyribosomes; regional and developmental expression in mouse brain. PLoS One 8: e58296.
62. Sittler A, Devys D, Weber C, Mandel JL (1996) Alternative splicing of exon 14 determines nuclear or cytoplasmic localisation of fmr1 protein isoforms. Hum Mol Genet 5: 95-102. (Pubitemid 26018279)
63. Collins SC, Bray SM, Suhl JA, Cutler DJ, Coffee B, et al. (2010) Identification of novel FMR1 variants by massively parallel sequencing in developmentally delayed males. Am J Med Genet A 152A: 2512-2520.
64. Schmidt-Zachmann MS, Nigg EA (1993) Protein localization to the nucleolus: a search for targeting domains in nucleolin. J Cell Sci 105 (Pt 3): 799-806. (Pubitemid 23243212)
65. Ceman S, Nelson R, Warren ST (2000) Identification of mouse YB1/p50 as a component of the FMRP-associated mRNP particle. Biochem Biophys Res Commun 279: 904-908. (Pubitemid 32042874)
66. Narayanan U, Nalavadi V, Nakamoto M, Thomas G, Ceman S, et al. (2008) S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade. J Biol Chem 283: 18478-18482.
67. Bassell GJ, Warren ST (2008) Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60: 201-214.
68. Darnell JC, Klann E (2013) The translation of translational control by FMRP: therapeutic targets for FXS. Nat Neurosci.
69. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, et al. (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65: 905-914. (Pubitemid 121001321)
70. Yang C, Maiguel DA, Carrier F (2002) Identification of nucleolin and nucleophosmin as genotoxic stress-responsive RNA-binding proteins. Nucleic Acids Res 30: 2251-2260. (Pubitemid 34567946)
71. Eberth A, Ahmadian MR (2009) In vitro GEF and GAP assays. Current protocols in cell biology/editorial board, Juan S Bonifacino [et al] Chapter 14: Unit 14 19.
72. Jaiswal M, Gremer L, Dvorsky R, Haeusler LC, Cirstea IC, et al. (2011) Mechanistic insights into specificity, activity, and regulatory elements of the regulator of G-protein signaling (RGS)-containing Rho-specific guanine nucleotide exchange factors (GEFs) p115, PDZ-RhoGEF (PRG), and leukemia-associated RhoGEF (LARG). J Biol Chem 286: 18202-18212.
73. Robinson MS, Sahlender DA, Foster SD (2010) Rapid inactivation of proteins by rapamycin-induced rerouting to mitochondria. Dev Cell 18: 324-331.
74. Callebaut C, Jacotot E, Guichard G, Krust B, Rey-Cuille M, et al. (1996) Inhibition of HIV infection by pseudopeptides blocking viral envelope glycoprotein-mediated membrane fusion and cell death. Virology 218: 181-192. (Pubitemid 26133097)
75. Callebaut C, Jacotot E, Krust B, Guichard G, Blanco J, et al. (1997) Pseudopeptide TASP inhibitors of HIV entry bind specifically to a 95-kDa cell surface protein. J Biol Chem 272: 7159-7166. (Pubitemid 27166422)
76. Wojcik F, Mosca S, Hartmann L (2012) Solid-phase synthesis of asymmetrically branched sequence-defined poly/oligo(amidoamines). J Org Chem 77: 4226-4234.